Table 3.
Baseline data available from patients who were allocated to the study (intervention = 1034, control = 501)
| |
Type 2 Diabetes |
Coronary artery disease |
Congestive heart failure |
|||
|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention | Control | |
| Number of patients |
770 |
359 |
172 |
97 |
92 |
45 |
| Age (years) |
64.6 (9.4) |
65.6 (9.5) |
65.4 (9.4) |
66.0 (8.6) |
67.3 (7.9) |
62.4 (7.7) |
| Sex (% male) |
58.3 |
54.0 |
69.2 |
73.2 |
65.2 |
64.4 |
| Age at self reported year of diagnosis |
54.3 (11.1) |
56.1 (11.8) |
60.8 (10.2) |
61.3 (10.1) |
63.9 (7.9) |
56.8 (9.3) |
| 311 |
145 |
121 |
69 |
51 |
25 |
|
| Self-reported duration of disease |
10.3 (8.4) |
9.2 (8.2) |
4.7 (6.6) |
4.8 (7.6) |
4.4 (5.4) |
4.2 (3.7) |
| 302 |
142 |
120 |
68 |
51 |
25 |
|
| Body mass index |
32.3 (6.2) |
31.9 (5.7) |
28.3 (4.1) |
28.8 (5.1) |
30.2 (6.6) |
29.9 (6.9) |
| 727 |
338 |
164 |
91 |
81 |
42 |
|
| Waist circumference (M/F) |
109.9 (14.4)/ 106.8 (15.5) |
110.1 (12.8)/ 104.8 (15.1) |
100.3 (11.0)/ 95.1 (12.8) |
102.9 (11.7)/ 91.5 (12.6) |
106.7 (12.8)/ 94.1 (14.6) |
108.0 (17.9)/ 89.6 (17.3) |
| 429/298 |
182/156 |
116/47 |
66/25 |
55/25 |
25/16 |
|
| Systolic blood pressure (mmHg) |
143.4 (20.0) |
143.1 (20.2) |
137.6 (20.5) |
139.9 (18.2) |
132.9 (23.7) |
127.6 (22.7) |
| 727 |
337 |
163 |
91 |
81 |
42 |
|
| Diastolic blood pressure (mmHg) |
84.2 (11.1) |
84.1 (10.8) |
81.0 (12.2) |
82.1 (10.5) |
81.3 (14.1) |
80.2 (11.5) |
| 727 |
338 |
163 |
91 |
81 |
42 |
|
| Serum total cholesterol (mmol/l) |
4.4 (1.1) |
4.4 (0.9) |
3.8 (0.9) |
3.8 (1.0) |
4.0 (1.2) |
4.0 (1.4) |
| 225 |
121 |
66 |
46 |
23 |
12 |
|
| Serum HDL cholesterol (mmol/l) |
1.2 (0.4) |
1.3 (0.4) |
1.4 (0.4) |
1.3 (0.4) |
1.1 (0.4) |
1.3 (0.5) |
| 219 |
119 |
65 |
45 |
23 |
11 |
|
| Serum LDL cholesterol (mmol/l) |
2.3 (0.8) |
2.4 (0.8) |
1.9 (0.6) |
1.9 (0.7) |
2.1 (0.9) |
2.2 (0.9) |
| 210 |
115 |
65 |
45 |
21 |
11 |
|
| Lipid lowering medication (%) |
24.7 |
20.3 |
60.5 |
55.7 |
38.0 |
22.2 |
| 190 |
73 |
104 |
54 |
35 |
10 |
|
| Daily smokers (%) |
12.7 |
11.0 |
11.9 |
10.1 |
12.7 |
12.2 |
| 88/691 |
36/327 |
19/160 |
9/89 |
10/79 |
5/41 |
|
| Hb1Ac (%) |
7.5 (1.1) |
7.7 (1.7) |
|
|
|
|
| 415 |
224 |
|
|
|
|
|
| Oral antidiabetic drug and insulin (%) |
12.3 |
13.1 |
|
|
|
|
| 95 |
47 |
|
|
|
|
|
| Oral antidiabetic drug (%) |
34.0 |
29.8 |
|
|
|
|
| 262 |
107 |
|
|
|
|
|
| Insulin (%) |
16.8 |
16.7 |
|
|
|
|
| |
129 |
60 |
|
|
|
|
| SCORE1 |
8.0 (6.3) |
7.6 (7.9) |
|
|
|
|
| 215 |
115 |
|
|
|
|
|
| NYHA2 |
|
|
|
|
2.4 (1.4) |
2.5 (1.4) |
| 52 | 30 | |||||
1 Score index includes: Sex, Age, Total Chol, HDL and BP, smoking status.
2 New York Heart Association index on angina pectoris.